Ning Feng 11/10/23 Ning Feng 11/10/23 Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal Read More Tianjun Song 5/17/23 Tianjun Song 5/17/23 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor Read More Tianjun Song 4/4/23 Tianjun Song 4/4/23 BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read More Tianjun Song 3/20/23 Tianjun Song 3/20/23 BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read More Tianjun Song 3/17/23 Tianjun Song 3/17/23 YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ Read More Tianjun Song 3/10/23 Tianjun Song 3/10/23 Biocytogen Announces RenLite® Licensing Agreement with Janssen Read More Tianjun Song 3/3/23 Tianjun Song 3/3/23 Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 Read More Tianjun Song 2/24/23 Tianjun Song 2/24/23 Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) Read More Tianjun Song 2/20/23 Tianjun Song 2/20/23 Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares Read More Tianjun Song 11/8/22 Tianjun Song 11/8/22 Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 Ascletis announce signing license and supply agreement of ritonavir for COVID-19 drug PAXLOVID™ in mainland China With Pfizer Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 XtalPi Announces Research Collaboration with Janssen Read More Tianjun Song 10/28/22 Tianjun Song 10/28/22 JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Read More Ning Feng 10/26/22 Ning Feng 10/26/22 HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers Read More Ning Feng 10/24/22 Ning Feng 10/24/22 C4XD and HitGen to collaborate in inflammation hit identification project Read More Ning Feng 10/11/22 Ning Feng 10/11/22 IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder Read More Ning Feng 9/29/22 Ning Feng 9/29/22 Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc Read More Ning Feng 9/27/22 Ning Feng 9/27/22 Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv) Read More Older Posts
Ning Feng 11/10/23 Ning Feng 11/10/23 Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal Read More
Tianjun Song 5/17/23 Tianjun Song 5/17/23 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor Read More
Tianjun Song 4/4/23 Tianjun Song 4/4/23 BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read More
Tianjun Song 3/20/23 Tianjun Song 3/20/23 BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read More
Tianjun Song 3/17/23 Tianjun Song 3/17/23 YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ Read More
Tianjun Song 3/10/23 Tianjun Song 3/10/23 Biocytogen Announces RenLite® Licensing Agreement with Janssen Read More
Tianjun Song 3/3/23 Tianjun Song 3/3/23 Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 Read More
Tianjun Song 2/24/23 Tianjun Song 2/24/23 Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23 Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares Read More
Tianjun Song 11/8/22 Tianjun Song 11/8/22 Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 Ascletis announce signing license and supply agreement of ritonavir for COVID-19 drug PAXLOVID™ in mainland China With Pfizer Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 XtalPi Announces Research Collaboration with Janssen Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22 JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Read More
Ning Feng 10/26/22 Ning Feng 10/26/22 HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers Read More
Ning Feng 10/24/22 Ning Feng 10/24/22 C4XD and HitGen to collaborate in inflammation hit identification project Read More
Ning Feng 10/11/22 Ning Feng 10/11/22 IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder Read More
Ning Feng 9/29/22 Ning Feng 9/29/22 Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc Read More
Ning Feng 9/27/22 Ning Feng 9/27/22 Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv) Read More
